UniProt ID | TBL3_HUMAN | |
---|---|---|
UniProt AC | Q12788 | |
Protein Name | Transducin beta-like protein 3 | |
Gene Name | TBL3 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 808 | |
Subcellular Localization | Nucleus, nucleolus . | |
Protein Description | ||
Protein Sequence | MAETAAGVGRFKTNYAVERKIEPFYKGGKAQLDQTGQHLFCVCGTRVNILEVASGAVLRSLEQEDQEDITAFDLSPDNEVLVTASRALLLAQWAWQEGSVTRLWKAIHTAPVATMAFDPTSTLLATGGCDGAVRVWDIVRHYGTHHFRGSPGVVHLVAFHPDPTRLLLFSSATDAAIRVWSLQDRSCLAVLTAHYSAVTSLAFSADGHTMLSSGRDKICIIWDLQSCQATRTVPVFESVEAAVLLPEEPVSQLGVKSPGLYFLTAGDQGTLRVWEAASGQCVYTQAQPPGPGQELTHCTLAHTAGVVLTATADHNLLLYEARSLRLQKQFAGYSEEVLDVRFLGPEDSHVVVASNSPCLKVFELQTSACQILHGHTDIVLALDVFRKGWLFASCAKDQSVRIWRMNKAGQVMCVAQGSGHTHSVGTVCCSRLKESFLVTGSQDCTVKLWPLPKALLSKNTAPDNGPILLQAQTTQRCHDKDINSVAIAPNDKLLATGSQDRTAKLWALPQCQLLGVFSGHRRGLWCVQFSPMDQVLATASADGTIKLWALQDFSCLKTFEGHDASVLKVAFVSRGTQLLSSGSDGLVKLWTIKNNECVRTLDAHEDKVWGLHCSRLDDHALTGASDSRVILWKDVTEAEQAEEQARQEEQVVRQQELDNLLHEKRYLRALGLAISLDRPHTVLTVIQAIRRDPEACEKLEATMLRLRRDQKEALLRFCVTWNTNSRHCHEAQAVLGVLLRREAPEELLAYEGVRAALEALLPYTERHFQRLSRTLQAAAFLDFLWHNMKLPVPAAAPTPWETHKGALP | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MAETAAGVG ------CCCCCCCCC | 23.89 | 22814378 | |
4 | Phosphorylation | ----MAETAAGVGRF ----CCCCCCCCCCC | 16.57 | 20068231 | |
12 | Acetylation | AAGVGRFKTNYAVER CCCCCCCCCCCCCCC | 34.20 | 26051181 | |
12 | Methylation | AAGVGRFKTNYAVER CCCCCCCCCCCCCCC | 34.20 | 115980105 | |
12 | Ubiquitination | AAGVGRFKTNYAVER CCCCCCCCCCCCCCC | 34.20 | 29967540 | |
13 | Phosphorylation | AGVGRFKTNYAVERK CCCCCCCCCCCCCCC | 30.65 | - | |
15 | Phosphorylation | VGRFKTNYAVERKIE CCCCCCCCCCCCCCC | 19.77 | 29496907 | |
20 | Sumoylation | TNYAVERKIEPFYKG CCCCCCCCCCCCCCC | 37.60 | - | |
20 | Ubiquitination | TNYAVERKIEPFYKG CCCCCCCCCCCCCCC | 37.60 | 29967540 | |
25 | Phosphorylation | ERKIEPFYKGGKAQL CCCCCCCCCCCEEEE | 21.31 | 24732914 | |
26 | Acetylation | RKIEPFYKGGKAQLD CCCCCCCCCCEEEEC | 62.66 | 19608861 | |
26 | Ubiquitination | RKIEPFYKGGKAQLD CCCCCCCCCCEEEEC | 62.66 | 22817900 | |
29 | Ubiquitination | EPFYKGGKAQLDQTG CCCCCCCEEEECCCC | 41.44 | 21963094 | |
105 | Ubiquitination | GSVTRLWKAIHTAPV CCHHHHHHHHHHCCC | 41.89 | - | |
105 | Acetylation | GSVTRLWKAIHTAPV CCHHHHHHHHHHCCC | 41.89 | 26051181 | |
142 | Phosphorylation | VWDIVRHYGTHHFRG HHHHHHHHCCCCCCC | 17.10 | 25867546 | |
144 | Phosphorylation | DIVRHYGTHHFRGSP HHHHHHCCCCCCCCC | 12.66 | 25867546 | |
150 | Phosphorylation | GTHHFRGSPGVVHLV CCCCCCCCCCEEEEE | 17.77 | 25867546 | |
170 | O-linked_Glycosylation | PTRLLLFSSATDAAI CCEEEEEEECCHHHH | 21.02 | 23301498 | |
173 | O-linked_Glycosylation | LLLFSSATDAAIRVW EEEEEECCHHHHHHH | 28.28 | 23301498 | |
257 | Phosphorylation | VSQLGVKSPGLYFLT HHHCCCCCCCEEEEE | 23.07 | 29255136 | |
261 | Phosphorylation | GVKSPGLYFLTAGDQ CCCCCCEEEEECCCC | 11.49 | 26074081 | |
264 | Phosphorylation | SPGLYFLTAGDQGTL CCCEEEEECCCCCEE | 20.78 | 26074081 | |
328 | Ubiquitination | ARSLRLQKQFAGYSE HHHHHHHHHHCCCCC | 52.56 | 21906983 | |
387 | Acetylation | LALDVFRKGWLFASC EEEHHHHCCCCCHHC | 42.87 | 26051181 | |
396 | Acetylation | WLFASCAKDQSVRIW CCCHHCCCCCCEEEE | 61.70 | 26051181 | |
407 | Ubiquitination | VRIWRMNKAGQVMCV EEEEEECCCCCEEEE | 44.55 | 21963094 | |
407 | Sumoylation | VRIWRMNKAGQVMCV EEEEEECCCCCEEEE | 44.55 | 28112733 | |
407 | Acetylation | VRIWRMNKAGQVMCV EEEEEECCCCCEEEE | 44.55 | 26051181 | |
418 | Phosphorylation | VMCVAQGSGHTHSVG EEEEEECCCCCCCHH | 18.47 | - | |
433 | Acetylation | TVCCSRLKESFLVTG HEEECCCCCCEEECC | 50.64 | 26051181 | |
433 | Ubiquitination | TVCCSRLKESFLVTG HEEECCCCCCEEECC | 50.64 | 29967540 | |
435 | Phosphorylation | CCSRLKESFLVTGSQ EECCCCCCEEECCCC | 23.46 | 20068231 | |
439 | Phosphorylation | LKESFLVTGSQDCTV CCCCEEECCCCCCEE | 33.01 | 20068231 | |
441 | Phosphorylation | ESFLVTGSQDCTVKL CCEEECCCCCCEEEE | 17.30 | 20068231 | |
445 | Phosphorylation | VTGSQDCTVKLWPLP ECCCCCCEEEEEECC | 29.03 | 20068231 | |
453 | Ubiquitination | VKLWPLPKALLSKNT EEEEECCHHHHCCCC | 60.39 | 21906983 | |
458 | Ubiquitination | LPKALLSKNTAPDNG CCHHHHCCCCCCCCC | 59.28 | 21906983 | |
460 | Phosphorylation | KALLSKNTAPDNGPI HHHHCCCCCCCCCCE | 43.22 | 28555341 | |
480 | Ubiquitination | TTQRCHDKDINSVAI ECCCCCCCCCCEEEE | 36.52 | 29967540 | |
480 | Acetylation | TTQRCHDKDINSVAI ECCCCCCCCCCEEEE | 36.52 | 25953088 | |
492 | Ubiquitination | VAIAPNDKLLATGSQ EEECCCCCEECCCCC | 52.63 | 21906983 | |
496 | Phosphorylation | PNDKLLATGSQDRTA CCCCEECCCCCCHHH | 37.02 | 20860994 | |
501 | Methylation | LATGSQDRTAKLWAL ECCCCCCHHHHHHCC | 29.01 | 115918301 | |
502 | Phosphorylation | ATGSQDRTAKLWALP CCCCCCHHHHHHCCC | 36.11 | 25599653 | |
504 | Ubiquitination | GSQDRTAKLWALPQC CCCCHHHHHHCCCCC | 43.90 | - | |
504 | Acetylation | GSQDRTAKLWALPQC CCCCHHHHHHCCCCC | 43.90 | 26051181 | |
557 | Ubiquitination | LQDFSCLKTFEGHDA ECCCCCCCEECCCCC | 56.34 | 21963094 | |
557 | Acetylation | LQDFSCLKTFEGHDA ECCCCCCCEECCCCC | 56.34 | 26051181 | |
588 | Ubiquitination | SGSDGLVKLWTIKNN CCCCCEEEEEEEECC | 43.26 | 23503661 | |
593 | Ubiquitination | LVKLWTIKNNECVRT EEEEEEEECCEEEEE | 46.47 | 23503661 | |
593 | Acetylation | LVKLWTIKNNECVRT EEEEEEEECCEEEEE | 46.47 | 25953088 | |
607 | Acetylation | TLDAHEDKVWGLHCS EEECCCCCEEEEEEC | 36.58 | 25825284 | |
607 | Ubiquitination | TLDAHEDKVWGLHCS EEECCCCCEEEEEEC | 36.58 | 29967540 | |
622 | Phosphorylation | RLDDHALTGASDSRV CCCCCCCCCCCCCEE | 31.33 | 20068231 | |
625 | Phosphorylation | DHALTGASDSRVILW CCCCCCCCCCEEEEE | 37.15 | 20068231 | |
633 | Acetylation | DSRVILWKDVTEAEQ CCEEEEEEECHHHHH | 38.58 | 26051181 | |
633 | Ubiquitination | DSRVILWKDVTEAEQ CCEEEEEEECHHHHH | 38.58 | 21906983 | |
636 | Phosphorylation | VILWKDVTEAEQAEE EEEEEECHHHHHHHH | 39.34 | 20068231 | |
664 | Acetylation | LDNLLHEKRYLRALG HHHHHHHHHHHHHHC | 35.28 | 25953088 | |
664 | Ubiquitination | LDNLLHEKRYLRALG HHHHHHHHHHHHHHC | 35.28 | 21906983 | |
666 | Phosphorylation | NLLHEKRYLRALGLA HHHHHHHHHHHHCHH | 16.17 | 24043423 | |
675 | Phosphorylation | RALGLAISLDRPHTV HHHCHHHCCCCCHHH | 20.71 | 24043423 | |
698 | Ubiquitination | RDPEACEKLEATMLR HCHHHHHHHHHHHHH | 52.06 | 21963094 | |
698 | Acetylation | RDPEACEKLEATMLR HCHHHHHHHHHHHHH | 52.06 | 23749302 | |
702 | Phosphorylation | ACEKLEATMLRLRRD HHHHHHHHHHHHHHH | 13.83 | 29083192 | |
711 | Acetylation | LRLRRDQKEALLRFC HHHHHHHHHHHHHHH | 49.60 | 26822725 | |
711 | Ubiquitination | LRLRRDQKEALLRFC HHHHHHHHHHHHHHH | 49.60 | 22817900 | |
750 | Phosphorylation | APEELLAYEGVRAAL CCHHHHHHHHHHHHH | 17.12 | 28152594 | |
763 | Phosphorylation | ALEALLPYTERHFQR HHHHHHHHHHHHHHH | 22.62 | 28152594 | |
764 | Phosphorylation | LEALLPYTERHFQRL HHHHHHHHHHHHHHH | 25.30 | 28152594 | |
798 | Phosphorylation | PVPAAAPTPWETHKG CCCCCCCCCCCCCCC | 35.99 | 28555341 | |
804 | Ubiquitination | PTPWETHKGALP--- CCCCCCCCCCCC--- | 53.98 | 21906983 | |
804 | Methylation | PTPWETHKGALP--- CCCCCCCCCCCC--- | 53.98 | 42372497 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of TBL3_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of TBL3_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of TBL3_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
AATF_HUMAN | AATF | physical | 26344197 | |
MPP10_HUMAN | MPHOSPH10 | physical | 26344197 | |
NOC2L_HUMAN | NOC2L | physical | 26344197 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-26, AND MASS SPECTROMETRY. |